Navigation Links
Patient Advocates Ask FDA to Let Them Help Define Risk
Date:10/5/2011

ollow up with a proposal outlining specifics for more frequent and regular communication between the patient community and FDA on benefit-risk determinations. While mechanisms currently exist for patient input on this topic, they add, the opportunity to provide such input doesn't necessarily occur at the time that critical issues are being deliberated and may not represent a broad spectrum of patient views.

"We have had discussions at length within the patient community as to what the most appropriate milestones should be for patient contribution," the letters note. They go on to say that the rare disease patient advocates have concluded that the two milestones should be:

1) When the IND (Investigational New Drug Application) or IDE (Investigational Device Exemption) is filed and,

2) Any point at which the agency (FDA) decides, based on issues related to risk, that it must disapprove or delay commencement of a clinical trial or impose an unscheduled suspension on an existing clinical trial.

In addition to laying out specific suggestions as to how and when patient input might be submitted, the letters propose that FDA create a portal on its website, www.fda.gov, where it can post specific requests for patient contributions to certain issues.

"The patient groups who have signed this letter represent a broad spectrum of diseases, some rare and some more common. But all patients with chronic or rare diseases know that the benefit-risk ratio for any new drug or device is an important consideration," said Diane Dorman, NORD's vice president of public policy. "We are pleased that the patient community has been able to band together to bring these proposals to the FDA, and that senior FDA officials have been so receptive."

NORD is an umbrella organization providing advocacy on behalf of the 30 million Americans with rare diseases, working with its member organizations, which represent patients with
'/>"/>

SOURCE National Organization for Rare Disorder (NORD)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NxStage Says Thank You to Patients and Care Partners at the 2nd Annual NxStageUsers Meet-Up and Conference in New Orleans
2. Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Capecitabine in Patients with Metastatic Colorectal Cancer
3. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
4. Incisive Surgical Launches New National Patient Advocacy Campaign -- Eliminate Traumatic Metal Skin Staples for Routine Skin Closure
5. voiceTech Launches ServiceLink-Rx, the First Comprehensive Patient Communication Platform for Retail Pharmacies
6. NxStage System One Patients Join Patient Advocacy Groups on Capitol Hill
7. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
8. First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men
9. FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet
10. Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
11. Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- The Physician-Patient Alliance for Health & Safety ... "Surviving Your Hospital Stay: Physician-Patient Alliance for Health ... A sentence was omitted from the release. ... is a member of the National Coalition to Promote ... the National Coalition to Promote Continuous Monitoring of Patients ...
(Date:7/31/2015)... July 31, 2015 According to a ... (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services ... (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published by MarketsandMarkets, ... 6.1 Billion by 2020, at a CAGR of 7.6%.from 2015 ... market data T ables and 37 ...
(Date:7/31/2015)... , July 31, 2015 Quietly, ... of experience, the domestic pharmaceutical industry is strong, with ... products to high international standards. One place ... is in sub-Saharan Africa: Morocco has quietly become the ... South Africa . Indeed, Moroccan pharma companies ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3
... Jan. 21, 2011 Matrixx Initiatives, Inc. (Nasdaq: ... healthcare company that develops and markets Zicam® products, today ... by the Agreement and Plan of Merger, dated as ... Holdings, Inc. ("Wonder") and Wonder Holdings Acquisition Corp. (the ...
... Ariz., Jan. 20, 2011 Matrixx Initiatives, Inc. (Nasdaq: ... markets Zicam® products, today announced financial results for its fiscal ... For the third quarter ended December 31, 2010, ... below the $28.5 million in net sales for the comparable ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 2Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 3Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 4Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 5Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 2Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 3Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 4Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 5
(Date:7/31/2015)... ... , ... According to WFLA on July 16th, Sarasota has seen ... overdoses. Thricefold deaths have held steady over the last “couple of months” according to ... which was spurred by the crackdown of prescription painkillers. Many users who were addicted ...
(Date:7/31/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... of Midwives delivered the 100th baby at Beaumont Hospital's Karmanos Center for ... home-like environment for expectant mothers looking for a safe natural childbirth experience. With ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to announce that ... in a mobile application format available on iPhones, iPads, and Android smartphones and ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... are 100% organic, natural, therapeutic-grade oils from ingredients sourced all over the world, ... that “With considerable effort, we have developed the highest-quality oils in the industry, ...
(Date:7/31/2015)... Baltimore, MD (PRWEB) , ... July 31, 2015 ... ... Lure Docs of All Types " from NBC talked about a woman’s unfortunate ... dermatology. He performed sclerotherapy on her face, which resulted in blistering, swelling, bruising, ...
Breaking Medicine News(10 mins):Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3
... , , , ... ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products ... 4, 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , ... the quarter was $19.8 million, or 17.0% higher than the second quarter ...
... , , Results , , ... Corporation (Nasdaq: DRRX ) announced today financial results for the ... the three months ended June 30, 2009, compared to $6.3 million for ... ended June 30, 2009 was $7.5 million, compared to a net loss ...
... , , BIRMINGHAM, Ala., Aug. 3 ... reports Operating Income of $50.4 million, or $1.52 per diluted share for ... million, or $1.62 per diluted share. For the six months ended June ... and Net Income was $82.2 million, or $2.46 per diluted share. , ...
... activities, such as painting, study finds , MONDAY, Aug. ... time in front of the television, the computer and video ... a new study suggests. , American and Spanish researchers examined ... boys and girls, 3 to 8 years old. For seven ...
... An international ... may lead to new areas for drug development in melanoma - a cancer that is ... ... identified a new method for selectively killing metastatic melanoma cells, which may lead to new ...
... , NATICK, Mass., Aug. 3 Boston ... participate in the BMO Capital Markets 9(th) Annual Focus on ... Ray Elliott, President and Chief Executive Officer, will make a ... a.m. E.T. Following the presentation, Sam Leno, Executive Vice ...
Cached Medicine News:Health News:ATS Medical Announces Second Quarter 2009 Results 2Health News:ATS Medical Announces Second Quarter 2009 Results 3Health News:ATS Medical Announces Second Quarter 2009 Results 4Health News:ATS Medical Announces Second Quarter 2009 Results 5Health News:ATS Medical Announces Second Quarter 2009 Results 6Health News:ATS Medical Announces Second Quarter 2009 Results 7Health News:ATS Medical Announces Second Quarter 2009 Results 8Health News:ATS Medical Announces Second Quarter 2009 Results 9Health News:ATS Medical Announces Second Quarter 2009 Results 10Health News:ATS Medical Announces Second Quarter 2009 Results 11Health News:DURECT Corporation Announces Second Quarter 2009 Financial 2Health News:DURECT Corporation Announces Second Quarter 2009 Financial 3Health News:DURECT Corporation Announces Second Quarter 2009 Financial 4Health News:DURECT Corporation Announces Second Quarter 2009 Financial 5Health News:DURECT Corporation Announces Second Quarter 2009 Financial 6Health News:DURECT Corporation Announces Second Quarter 2009 Financial 7Health News:DURECT Corporation Announces Second Quarter 2009 Financial 8Health News:DURECT Corporation Announces Second Quarter 2009 Financial 9Health News:ProAssurance Reports Second Quarter 2009 Results 2Health News:ProAssurance Reports Second Quarter 2009 Results 3Health News:ProAssurance Reports Second Quarter 2009 Results 4Health News:ProAssurance Reports Second Quarter 2009 Results 5Health News:ProAssurance Reports Second Quarter 2009 Results 6Health News:ProAssurance Reports Second Quarter 2009 Results 7Health News:ProAssurance Reports Second Quarter 2009 Results 8Health News:ProAssurance Reports Second Quarter 2009 Results 9Health News:ProAssurance Reports Second Quarter 2009 Results 10Health News:ProAssurance Reports Second Quarter 2009 Results 11Health News:ProAssurance Reports Second Quarter 2009 Results 12Health News:ProAssurance Reports Second Quarter 2009 Results 13Health News:Young Kids' Screen Time May Raise Blood Pressure 2Health News:Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 2Health News:Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 3
The ACP 215 is the automated closed system cell processor with integrated process control....
... Blood collection centers throughout the world are ... improve the safety of the blood supply ... a constantly shrinking donor base. Clearly, these ... self-sufficient, to better manage their existing donor ...
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
Medicine Products: